These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16441267)

  • 1. Alcohol biomarker screening in medical and surgical settings.
    Miller PM; Spies C; Neumann T; Javors MA; Hoyumpa AM; Roache J; Webb A; Kashi M; Sharkey FE; Anton RF; Egan BM; Basile J; Nguyen S; Fleming MF; Dillie KS
    Alcohol Clin Exp Res; 2006 Feb; 30(2):185-93. PubMed ID: 16441267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validity of carbohydrate-deficient transferrin (%CDT), gamma-glutamyltransferase (gamma-GT) and mean corpuscular erythrocyte volume (MCV) as biomarkers for chronic alcohol abuse: a study in patients with alcohol dependence and liver disorders of non-alcoholic and alcoholic origin.
    Hock B; Schwarz M; Domke I; Grunert VP; Wuertemberger M; Schiemann U; Horster S; Limmer C; Stecker G; Soyka M
    Addiction; 2005 Oct; 100(10):1477-86. PubMed ID: 16185209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients admitted to emergency services for drunkenness: moderate alcohol users or harmful drinkers?
    Reynaud M; Schwan R; Loiseaux-Meunier MN; Albuisson E; Deteix P
    Am J Psychiatry; 2001 Jan; 158(1):96-9. PubMed ID: 11136639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical alcohol screening in primary health care.
    Miller PM; Anton RF
    Addict Behav; 2004 Sep; 29(7):1427-37. PubMed ID: 15345274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-benefit analysis of a new alcohol biomarker, carbohydrate deficient transferrin, in a chronic illness primary care sample.
    Dillie KS; Mundt M; French MT; Fleming MF
    Alcohol Clin Exp Res; 2005 Nov; 29(11):2008-14. PubMed ID: 16340458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of carbohydrate deficient transferrin as an indicator of alcohol consumption during treatment and follow-up.
    Anton RF
    Alcohol Clin Exp Res; 1996 Nov; 20(8 Suppl):54A-56A. PubMed ID: 8947235
    [No Abstract]   [Full Text] [Related]  

  • 7. Carbohydrate-deficient transferrin, gamma-glutamyltransferase, and macrocytic volume as biomarkers of alcohol problems in women.
    Allen JP; Litten RZ; Fertig JB; Sillanaukee P
    Alcohol Clin Exp Res; 2000 Apr; 24(4):492-6. PubMed ID: 10798585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of an increased blood level of GGT, CDT, methanol, acetone and isopropanol in alcohol intoxicated automobile drivers. Alcoholism indicators instead of medical-psychological examination].
    Iffland R; Balling MP; Börsch G; Herold C; Kaschade W; Löffler T; Schmidtmann U; Stettner J
    Blutalkohol; 1994 Sep; 31(5):273-314. PubMed ID: 7986482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revealing alcohol abuse: to ask or to test?
    Alling C; Chick JD; Anton R; Mayfield RD; Salaspuro M; Helander A; Harris RA
    Alcohol Clin Exp Res; 2005 Jul; 29(7):1257-63. PubMed ID: 16088981
    [No Abstract]   [Full Text] [Related]  

  • 10. Limitations of CDT and GGT in detecting relapses in patients attending an alcohol problems clinic.
    Limin S; Jarvie DR; Chick J; Simpson D
    Scott Med J; 1999 Oct; 44(5):140-2. PubMed ID: 10629909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Carbohydrate-deficient transferrin. A new, highly specific marker for chronic alcohol consumption].
    Seitz G; Stickel F; Fiehn W; Werle E; Simanowski UA; Seitz HK
    Dtsch Med Wochenschr; 1995 Mar; 120(12):391-5. PubMed ID: 7705200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of carbohydrate-deficient transferrin for detection of alcohol abuse in patients with liver dysfunction.
    Stauber RE; Stepan V; Trauner M; Wilders-Truschnig M; Leb G; Krejs GJ
    Alcohol Alcohol; 1995 Mar; 30(2):171-6. PubMed ID: 7662035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The new "alcohol marker" carbohydrate-deficient transferrin (CDT). Value for neurologic-psychiatric diagnosis].
    Wetterling T; Kanitz RD
    Fortschr Neurol Psychiatr; 1997 Aug; 65(8):337-46. PubMed ID: 9378446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of screening for unhealthy alcohol use with % carbohydrate deficient transferrin: results from a literature-based decision analytic computer model.
    Kapoor A; Kraemer KL; Smith KJ; Roberts MS; Saitz R
    Alcohol Clin Exp Res; 2009 Aug; 33(8):1440-9. PubMed ID: 19426168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphatidylethanol is superior to carbohydrate-deficient transferrin and γ-glutamyltransferase as an alcohol marker and is a reliable estimate of alcohol consumption level.
    Walther L; de Bejczy A; Löf E; Hansson T; Andersson A; Guterstam J; Hammarberg A; Asanovska G; Franck J; Söderpalm B; Isaksson A
    Alcohol Clin Exp Res; 2015 Nov; 39(11):2200-8. PubMed ID: 26503066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening trauma patients with the alcohol use disorders identification test and biomarkers of alcohol use.
    Neumann T; Gentilello LM; Neuner B; Weiss-Gerlach E; Schürmann H; Schröder T; Müller C; Haas NP; Spies CD
    Alcohol Clin Exp Res; 2009 Jun; 33(6):970-6. PubMed ID: 19302090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fetal Alcohol Syndrome and Maternal Alcohol Biomarkers in Sera: A Register-Based Case-Control Study.
    Niemelä S; Niemelä O; Ritvanen A; Gissler M; Bloigu A; Werler M; Surcel HM
    Alcohol Clin Exp Res; 2016 Jul; 40(7):1507-14. PubMed ID: 27228551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of carbohydrate-deficient transferrin (CDT) and a combination of GGT and CDT (GGT-CDT) to assess heavy alcohol consumption in traffic medicine.
    Bianchi V; Ivaldi A; Raspagni A; Arfini C; Vidali M
    Alcohol Alcohol; 2010; 45(3):247-51. PubMed ID: 20118108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood biomarkers of alcohol abuse.
    Bilban M; Vrhovec S; Karlovsek MZ
    Arh Hig Rada Toksikol; 2003 Dec; 54(4):253-9. PubMed ID: 14994647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exclusion of trisialo-transferrin from carbohydrate-deficient transferrin measurement: advantage in patients with chronic liver disease?
    Schöniger-Hekele M; Ramskogler K; Hartl D; Lesch OM; Müller C
    Wien Med Wochenschr; 2006 Apr; 156(7-8):216-22. PubMed ID: 16823539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.